Company Filing History:
2 out of 337 
1 out of 20 Years Active: 2011-2025
Title: Je-Yong Choi: Innovator in Peptide Research
Introduction
Je-Yong Choi is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of peptide research, particularly in relation to endothelial cells. His innovative work has implications for treating various angiogenesis-related diseases.
Latest Patents
Je-Yong Choi holds a patent for the "Use of a peptide that interacts with αvβ3 integrin of endothelial cells." This invention focuses on a method for inhibiting endothelial cell adhesion, migration, and angiogenesis. The peptide consists of at least 18 amino acids, including tyrosine-histidine (TY) or asparagines-histidine (NH), along with at least three hydrophobic amino acids with bulky side chains. This groundbreaking work provides a method for treating or preventing diseases related to angiogenesis.
Career Highlights
Choi is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His role in this institution allows him to bridge the gap between academic research and practical applications in the industry. His dedication to innovation is evident in his research and patent contributions.
Collaborations
Je-Yong Choi has collaborated with notable colleagues, including Ju-Ock Nam and Jung-Eun Kim. These partnerships enhance the scope and impact of his research endeavors.
Conclusion
Je-Yong Choi's work in peptide research exemplifies the potential of innovative solutions in addressing complex medical challenges. His contributions to the field are significant and pave the way for future advancements in treating angiogenesis-related diseases.